Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Assets: 2020-2024

Historic Assets for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $22.1 million.

  • Biofrontera's Assets fell 16.75% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year decrease of 16.75%. This contributed to the annual value of $22.1 million for FY2024, which is 20.88% down from last year.
  • Latest data reveals that Biofrontera reported Assets of $22.1 million as of FY2024, which was down 20.88% from $27.9 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Assets ranged from a high of $53.2 million in FY2021 and a low of $22.1 million during FY2024.
  • Its 3-year average for Assets is $33.6 million, with a median of $27.9 million in 2023.
  • In the last 5 years, Biofrontera's Assets surged by 120.48% in 2021 and then crashed by 45.11% in 2023.
  • Yearly analysis of 5 years shows Biofrontera's Assets stood at $24.1 million in 2020, then soared by 120.48% to $53.2 million in 2021, then dropped by 4.39% to $50.9 million in 2022, then crashed by 45.11% to $27.9 million in 2023, then decreased by 20.88% to $22.1 million in 2024.